Literature DB >> 3798920

Treatment of cranial osteomyelitis from disseminated coccidioidomycosis.

R Gillespie.   

Abstract

Entities:  

Mesh:

Year:  1986        PMID: 3798920      PMCID: PMC1307131     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  8 in total

1.  Cellular immune response in coccidioidomycosis.

Authors:  A Catanzaro; L E Spitler; K M Moser
Journal:  Cell Immunol       Date:  1975-02       Impact factor: 4.868

2.  Spectrum of in vivo and in vitro cell-mediated immune responses in coccidioidomycosis.

Authors:  R A Cox; J R Vivas
Journal:  Cell Immunol       Date:  1977-06-01       Impact factor: 4.868

Review 3.  Coccidioidomycosis. Part II.

Authors:  D J Drutz; A Catanzaro
Journal:  Am Rev Respir Dis       Date:  1978-04

Review 4.  Coccidioidomycosis. Part I.

Authors:  D J Drutz; A Catanzaro
Journal:  Am Rev Respir Dis       Date:  1978-03

5.  Coccidioidomycosis of the central nervous system.

Authors:  H E Einstein
Journal:  Adv Neurol       Date:  1974

6.  Dissemination of coccidioidomycosis in pregnancy.

Authors:  L E Smale; K G Waechter
Journal:  Am J Obstet Gynecol       Date:  1970-06-01       Impact factor: 8.661

7.  Successful treatment of spinal arachnoiditis due to coccidioidomycosis. Case report.

Authors:  D J Winston; T O Kurtz; J Fleischmann; D Morgan; U Batzdorf; W E Stern
Journal:  J Neurosurg       Date:  1983-08       Impact factor: 5.115

8.  Coccidioidomycosis: factors affecting the host-parasite interaction.

Authors:  D J Drutz; M Huppert
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

  8 in total
  2 in total

Review 1.  Coccidioidomycosis.

Authors:  D A Bronnimann; J N Galgiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

Review 2.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.